These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12972525)
1. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. Harlan LC; Clegg LX; Trimble EL J Clin Oncol; 2003 Sep; 21(18):3488-94. PubMed ID: 12972525 [TBL] [Abstract][Full Text] [Related]
2. Patterns of chemotherapy use for women with ovarian cancer: a population-based study. Cress RD; O'Malley CD; Leiserowitz GS; Campleman SL J Clin Oncol; 2003 Apr; 21(8):1530-5. PubMed ID: 12697877 [TBL] [Abstract][Full Text] [Related]
3. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196 [TBL] [Abstract][Full Text] [Related]
4. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Goff BA; Matthews BJ; Larson EH; Andrilla CH; Wynn M; Lishner DM; Baldwin LM Cancer; 2007 May; 109(10):2031-42. PubMed ID: 17420977 [TBL] [Abstract][Full Text] [Related]
5. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005). Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506 [TBL] [Abstract][Full Text] [Related]
6. Insurance status and the use of guideline therapy in the treatment of selected cancers. Harlan LC; Greene AL; Clegg LX; Mooney M; Stevens JL; Brown ML J Clin Oncol; 2005 Dec; 23(36):9079-88. PubMed ID: 16301598 [TBL] [Abstract][Full Text] [Related]
7. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. Mariotto AB; Feuer EJ; Harlan LC; Abrams J J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888 [TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer: patterns of surgical care across the United States. Goff BA; Matthews BJ; Wynn M; Muntz HG; Lishner DM; Baldwin LM Gynecol Oncol; 2006 Nov; 103(2):383-90. PubMed ID: 17005244 [TBL] [Abstract][Full Text] [Related]
9. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706 [TBL] [Abstract][Full Text] [Related]
10. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691 [TBL] [Abstract][Full Text] [Related]
11. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677 [TBL] [Abstract][Full Text] [Related]
12. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer treatment among women of different ethnicity in Hawaii. Issell BF; Maskarinec G; Pagano I; Gotay CC Cancer Invest; 2005; 23(6):497-504. PubMed ID: 16203657 [TBL] [Abstract][Full Text] [Related]
14. Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity. Naeim A; Hurria A; Leake B; Maly RC Crit Rev Oncol Hematol; 2006 Sep; 59(3):234-42. PubMed ID: 16829122 [TBL] [Abstract][Full Text] [Related]
15. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Chan JK; Kapp DS; Shin JY; Osann K; Leiserowitz GS; Cress RD; O'Malley C Gynecol Oncol; 2008 Jan; 108(1):95-9. PubMed ID: 17949796 [TBL] [Abstract][Full Text] [Related]
17. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. Schrag D; Earle C; Xu F; Panageas KS; Yabroff KR; Bristow RE; Trimble EL; Warren JL J Natl Cancer Inst; 2006 Feb; 98(3):163-71. PubMed ID: 16449676 [TBL] [Abstract][Full Text] [Related]
18. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473 [TBL] [Abstract][Full Text] [Related]
19. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. Freedman RA; He Y; Winer EP; Keating NL J Clin Oncol; 2009 Feb; 27(5):713-9. PubMed ID: 19103731 [TBL] [Abstract][Full Text] [Related]
20. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study. Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]